T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$8.01B |
| 2 |
Amazon
AMZN
|
+$5.64B |
| 3 |
Danaher
DHR
|
+$4.2B |
| 4 |
Gilead Sciences
GILD
|
+$4.09B |
| 5 |
JPMorgan Chase
JPM
|
+$4.03B |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.26% |
| 2 | Financials | 14.18% |
| 3 | Consumer Discretionary | 13.6% |
| 4 | Industrials | 11.64% |
| 5 | Technology | 10.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Prudential Financial
PRU
$43.2B
| $75.9M | 0.02% |
+1,039,100
| New | +$67.4M |
|
|
NBIS
652
Nebius Group N.V.
NBIS
$71.9B
| $75.8M | 0.02% |
+2,744,390
| New | +$69.7M |
|
653
CNA Financial
CNA
$13.8B
| $75.7M | 0.02% |
+2,320,600
| New | +$77.1M |
|
654
Jabil
JBL
$38.3B
| $75.2M | 0.02% |
+3,691,233
| New | +$69.7M |
|
655
AstraZeneca
AZN
$242B
| $75M | 0.02% |
+1,586,673
| New | +$80.8M |
|
656
Brown-Forman Class B
BF.B
$12.8B
| $75M | 0.02% |
+3,471,903
| New | +$78.1M |
|
657
Expeditors International
EXPD
$24.6B
| $74.8M | 0.02% |
+1,967,967
| New | +$73.7M |
|
658
Dominion Energy
D
$60.3B
| $74.8M | 0.02% |
+1,316,438
| New | +$77.1M |
|
|
OPTR
659
DELISTED
OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR
| $74.2M | 0.02% |
+5,127,008
| New | +$74.7M |
|
|
PIR
660
DELISTED
Pier 1 Imports, Inc.
PIR
| $73.9M | 0.02% |
+157,358
| New | +$73.7M |
|
|
WBA
661
DELISTED
Walgreens Boots Alliance
WBA
| $73.9M | 0.02% |
+1,671,726
| New | +$81.4M |
|
662
Alexandria Real Estate Equities
ARE
$8.33B
| $73.6M | 0.02% |
+1,119,652
| New | +$79.1M |
|
663
Littelfuse
LFUS
$11.5B
| $73.3M | 0.02% |
+982,590
| New | +$69.1M |
|
664
LCI Industries
LCII
$2.58B
| $73.3M | 0.02% |
+1,864,280
| New | +$69.3M |
|
665
Morningstar
MORN
$7.68B
| $72.5M | 0.02% |
+934,444
| New | +$64.7M |
|
666
Strategic Education
STRA
$1.85B
| $72.5M | 0.02% |
+1,484,155
| New | +$74.5M |
|
|
EQY
667
DELISTED
Equity One
EQY
| $72.5M | 0.02% |
+3,202,185
| New | +$78M |
|
668
Royal Gold
RGLD
$19.7B
| $72.1M | 0.02% |
+1,713,803
| New | +$92.8M |
|
|
CHS
669
DELISTED
Chicos FAS, Inc.
CHS
| $71.8M | 0.02% |
+4,207,300
| New | +$75.1M |
|
670
iShares Russell 2000 Value ETF
IWN
$14.7B
| $71.7M | 0.02% |
+834,510
| New | +$70.7M |
|
|
WMGI
671
DELISTED
Wright Medical Group Inc
WMGI
| $71.6M | 0.02% |
+2,731,532
| New | +$66.4M |
|
672
Alnylam Pharmaceuticals
ALNY
$30B
| $71.6M | 0.02% |
+2,308,100
| New | +$61.4M |
|
|
CLGX
673
DELISTED
Corelogic, Inc.
CLGX
| $71.5M | 0.02% |
+3,087,418
| New | +$78.7M |
|
674
Diamondback Energy
FANG
$57.2B
| $71.5M | 0.02% |
+2,144,490
| New | +$64.9M |
|
|
ESV
675
DELISTED
Ensco Rowan plc
ESV
| $71.3M | 0.02% |
+306,531
| New | +$72.1M |
|
Similar funds
T. Rowe Price Associates's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for T. Rowe Price Associates, which disclosed 2,429 positions worth $374B. Its ten largest holdings account for 12% of the portfolio.
Its largest position is Alphabet (Google) Class C: 378,851,526 shares worth $8.31B.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2013 buy was Alphabet (Google) Class C: 378,851,526 shares worth $8.31B.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $374B portfolio in Q2 2013.
- T. Rowe Price Associates disclosed 2,429 positions in Q2 2013, its first 13F filing on record.
Based on T. Rowe Price Associates's 13F filing for Q2 2013, filed 14 Aug 2013.